EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Cancer Letters

Description
An international journal providing a forum for original and pertinent contributions in cancer research

 

Status
active
Indexing
BIOSIS; Chemical Abstracts; Current Contents/Life Sciences; EMBASE; MEDLINE®; Oncology Information Service; Pascal et Francis (INST-CNRS); Scopus
Subject

Source type
Journal
Publisher
ISBN ISSN
0304-3835
First volume
1
Last volume
264+
Publish city
Amsterdam
Homepage
Description
CANCER LETTERS is a journal providing rapid publication of brief articles in the broad area of cancer research. The journal places emphasis on the molecular and cell biology of cancer, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. The primary criterion for publication is interest to a multidisciplinary audience. Papers should be brief but technically sound and substantiated by sufficient experimental detail. Clinical papers will be accepted if they contribute to the understanding of the basic mechanisms underlying disease.











Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )